Nature Communications (Jun 2016)

Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer

  • Yujun Hao,
  • Yardena Samuels,
  • Qingling Li,
  • Dawid Krokowski,
  • Bo-Jhih Guan,
  • Chao Wang,
  • Zhicheng Jin,
  • Bohan Dong,
  • Bo Cao,
  • Xiujing Feng,
  • Min Xiang,
  • Claire Xu,
  • Stephen Fink,
  • Neal J. Meropol,
  • Yan Xu,
  • Ronald A. Conlon,
  • Sanford Markowitz,
  • Kenneth W. Kinzler,
  • Victor E. Velculescu,
  • Henri Brunengraber,
  • Joseph E. Willis,
  • Thomas LaFramboise,
  • Maria Hatzoglou,
  • Guo-Fang Zhang,
  • Bert Vogelstein,
  • Zhenghe Wang

DOI
https://doi.org/10.1038/ncomms11971
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 13

Abstract

Read online

Cancer cells rely on glutamine to replenish the TCA cycle. Here, the authors show that oncogenic PIK3CAmutations drive this metabolic rewiring in colorectal cancer cells by up-regulating glutamate pyruvate transaminase expression, thus increasing sensitivity to glutamine starvation.